ID: ALA4289587

Max Phase: Preclinical

Molecular Formula: C78H84Cl2N8O25S

Molecular Weight: 1636.53

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCCCCCCCCCCCS(=O)(=O)N[C@H]1C(=O)N[C@@H]2Cc3ccc(c(Cl)c3)Oc3cc4cc(c3O)Oc3ccc(cc3Cl)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3NC(C)=O)[C@H]3NC(=O)[C@H](NC(O)[C@@H]4NC(=O)[C@@H](NC2=O)c2cc(O)cc(c2)Oc2cc1ccc2O)c1ccc(O)c(c1)-c1c(O)cc(O)cc1[C@H](C(=O)O)NC3=O

Standard InChI:  InChI=1S/C78H84Cl2N8O25S/c1-3-4-5-6-7-8-9-10-11-12-21-114(107,108)88-63-38-15-18-51(94)55(28-38)109-44-25-40(24-42(91)31-44)61-73(101)85-62-41-29-56(110-53-19-13-36(22-47(53)79)23-49(71(99)83-61)82-75(63)103)67(96)57(30-41)111-54-20-16-39(27-48(54)80)70(113-78-65(81-35(2)90)69(98)68(97)58(34-89)112-78)66-76(104)86-64(77(105)106)46-32-43(92)33-52(95)59(46)45-26-37(14-17-50(45)93)60(72(100)87-66)84-74(62)102/h13-20,22,24-33,49,58,60-66,68-70,74,78,84,88-89,91-98,102H,3-12,21,23,34H2,1-2H3,(H,81,90)(H,82,103)(H,83,99)(H,85,101)(H,86,104)(H,87,100)(H,105,106)/t49-,58-,60-,61+,62-,63-,64-,65-,66-,68-,69-,70-,74?,78+/m1/s1

Standard InChI Key:  NVRVLKHIKRWYIY-DDXPPTHOSA-N

Associated Targets(Human)

HEL 299 144 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Influenza A virus 11224 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

H3N2 subtype 329 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Influenza B virus 2113 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MDCK 10148 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Human coronavirus 229E 235 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 1636.53Molecular Weight (Monoisotopic): 1634.4645AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Szűcs Z, Kelemen V, Le Thai S, Csávás M, Rőth E, Batta G, Stevaert A, Vanderlinden E, Naesens L, Herczegh P, Borbás A..  (2018)  Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents.,  157  [PMID:30170320] [10.1016/j.ejmech.2018.08.058]

Source